Investors often look to consumer staples for defensive exposure that can weather softer discretionary spending. Yet FXG and VDC pursue that objective through distinctly different methods, which makes the comparison relevant for anyone balancing factor tilts with straightforward indexing. Both funds are passively managed within the consumer staples space, but they are not interchangeable. FXG follows a rules-based, factor-selected, equal-weight strategy, while VDC tracks a broad capitalization-weighted benchmark. Their differences in sector exposure, costs, and risk characteristics are worth examining closely for both individual and institutional allocators.
FXG aims to track the StrataQuant Consumer Staples AlphaDEX Index, which applies First Trust’s proprietary multi-factor selection process to stocks from the Russell 1000 Index. It selects names using growth and value criteria and then weights them toward higher-scoring holdings rather than by market cap. This produces a more balanced portfolio of roughly 41 holdings with a noticeable mid-cap tilt and periodic rebalancing. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Recent top holdings include food producers, ingredient suppliers, and healthcare distributors such as Cardinal Health, Pilgrim’s Pride, Freshpet, Post Holdings, Ingredion, Smithfield Foods, Seaboard, and McKesson. Because of names like McKesson and Cardinal Health, exposure extends somewhat into healthcare distribution. The fund’s 0.63% expense ratio reflects its factor-based construction and smaller asset base, which also contributes to more limited trading liquidity.
VDC follows the MSCI US Investable Market Consumer Staples 25/50 Index, a broad capitalization-weighted benchmark covering large-, mid-, and small-cap U.S. staples companies. It uses full replication where possible and holds approximately 106 stocks in line with index weights. This structure offers a direct, low-cost way to access the full U.S. consumer staples universe. The portfolio is heavily weighted toward mega-cap names such as WMT, COST, PG, and KO, followed by PM, PEP, MO, MDLZ, TGT, and CL. Roughly 98% of assets sit in the consumer defensive segment. With a 0.09% expense ratio and a multi-billion-dollar asset base, VDC provides clear advantages in cost, liquidity, and diversification across individual company risks.
Consumer staples have attracted attention as investors evaluate household spending resilience amid persistent inflation, higher borrowing costs, and moderating growth. Categories like food, beverages, household products, and tobacco typically deliver steadier demand, supporting defensive allocations during uncertain periods. At the same time, the sector contends with margin pressure from rising input costs and competition, while major retailers and manufacturers adjust to changing preferences and private-label growth. Capital has flowed selectively into defensive equities, with staples providing ballast during rotations away from higher-beta areas. Regulatory and tax issues, along with currency effects for global names, remain relevant risks. The breadth and concentration differences between the two funds influence how each participates in any sector move.
In recent periods, the funds have behaved in line with their designs. VDC’s results have been closely linked to its mega-cap holdings—Walmart, Costco, Procter & Gamble, and Coca-Cola—whose scale and pricing power have supported relative stability and reliable dividends. Concentration amplifies the impact of these names but also anchors the fund to the sector’s most liquid and durable businesses. FXG, meanwhile, has shown greater sensitivity to mid-cap food producers, ingredient suppliers, and protein companies, where earnings and commodity costs can fluctuate more sharply. Its equal-weight, factor-tilted approach reduces single-stock concentration yet introduces higher company-level volatility and portfolio turnover. Overall, VDC has delivered lower-beta, steadier positioning, while FXG has offered scope for factor-driven outperformance at the cost of higher fees and greater mid-cap exposure. These distinctions in volatility, concentration, and expense are central to evaluating either fund.
When I compared the structural features of these two ETFs, I turned to Tickeron’s AI Screener to cross-check industry positioning and volatility metrics. The tool allowed me to quickly filter staples-focused funds by cost, holdings count, and recent trend signals, which helped confirm the relative strengths I had already identified through standard data sources. This kind of targeted scan can surface nuances that manual review sometimes misses, especially when evaluating cost efficiency alongside diversification.
Based on the observable structural factors, Tickeron’s AI currently favors VDC. The Vanguard fund holds a clear advantage in cost efficiency (0.09% versus 0.63%), broader diversification across roughly 106 holdings, superior liquidity, and a larger, more established asset base. Its capitalization-weighted exposure to the sector’s most durable, cash-generative companies supports more consistent trend behavior and a lower-volatility profile. While FXG’s factor-driven, equal-weight design provides a legitimate path toward potential alpha, that comes with higher fees, greater turnover, and increased single-stock and mid-cap sensitivity. On balance, VDC’s combination of structural advantages, cost discipline, and defensive consistency makes it the more probable choice in this matchup.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Indicator exited the oversold zone, 20 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 55 cases where FXG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 41 of 47 cases over the following month. The odds of a continued upward trend are 87%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 258 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 180 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 65 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples